<DOC>
	<DOCNO>NCT00969852</DOCNO>
	<brief_summary>This study aim explore pharmacokinetics pharmacodynamics low dose sertraline [ 11C ] sertraline positron emission tomography ( PET ) study .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Sertraline After Low Dose Administration</brief_title>
	<detailed_description>Open , one arm , single sequence , 3-period , dose escalate study healthy volunteer investigate . Ten subject may enrol . Subjects receive baseline [ 11C ] sertraline PET . Period 1 Subjects receive 5 mg sertraline every day . After 6 day medication , pharmacokinetic PET study perform . Period 2 Subjects receive 25 mg sertraline every day . After 6 day medication , pharmacokinetic PET study perform . Period 3 Subjects receive 50 mg sertraline every day . After 6 day medication , pharmacokinetic PET study perform .</detailed_description>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Age : Between 20 50 year age , inclusive ( age base date give inform consent ) Weight : Over 55 kg , within Â±20 % ideal body weight Subject reliable willing make available study period , willing follow study protocol , give write informed consent voluntarily History significant clinical illness need medical caution , include cardiovascular , immunologic , hematologic , neuropsychiatric , respiratory , gastrointestinal , hepatic , renal disease chronic disease History significant surgical resection gastrointestinal tract except appendectomy Abnormal clinical laboratory finding , especially AST ALT &gt; 1.25 fold upper normal limit Subject phobia PET scan History evidence drug abuse Use prescriptive medication , Korean traditional medication consider acceptable clinical investigator last 14 day period first dose , use OTC medication consider acceptable clinical investigator last 7 day period first dose ( If use medication consider acceptable investigator , patient include ) Participation clinical trial drug within 2 month prior participation study Donation whole blood within 2 month unit blood within 1 month prior start study Judged inappropriate study investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Sertraline</keyword>
	<keyword>PET</keyword>
	<keyword>Serotonin receptor occupancy</keyword>
	<keyword>PK-PD Model</keyword>
</DOC>